Primary objectives:1.1 To investigate the differences between patients* and resident loved ones' perceptions of patients* health status and problematic ADLs.1.2 To study prospectively the effects of an acute COPD exacerbation on resident loved…
ID
Source
Brief title
Condition
- Bronchial disorders (excl neoplasms)
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The resident loved one, their perception of the person with COPD, and the
person with COPD will be compared by using the :
* Problematic ADLs using the Canadian Occupational Performance Measure (COPM)
* COPD Assessment Test (CAT)
* mMRC dyspnea scale
* Short-Form 12
* Instrumental Activities of Daily Living Scale (IADLS)
* EQ-5D
* Fatigue using the Subjective Fatigue subscale of the Checklist Individual
Strength
* Self-efficacy for home walking
Secondary outcome
The secondary study parameters will be:
* Hospital Anxiety and Depression scale (HADS)
* Care Dependency Scale (CDS)
* Daily symptoms checklist
* Current smoking status and smoking history
* Fat-free mass (using BIA), body weight and height
* Physical activity (using validated accelerometer)
* Informal and professional (medical) care <6 months
* Perceived social support using the Medical Outcome Study Social Support
Survey (MOSSSS)
* Post-bronchodilator spirometry
* Blood pressure, heart rate and oxygen saturation at rest
* Timed-up-and-go test
* Utrecht Coping List
* Caregiver burden and positive aspects of caregiving using the FACQ-PC
* A 35-item COPD knowledge questionnaire (self-developed, currently tested)
* Dutch relationship questionnaire 2003 (Uitgever: Pearson Assessment and
Information B.V.)
Other study parameters will be:
* Demographics, including marital status;
* Data on relationship of the loved one to the patient;
* Medical history;
* Current medication;
* Charlson co-morbidity index.
Background summary
Resident loved ones (mostly spouses or resident family members) are uniquely
positioned to witness the abilities/limitations that patients with Chronic
Obstructive Pulmonary Disease (COPD) experience during day-to-day life.
Moreover, resident loved ones can play an important role in COPD patients*
management and well-being. To date, however, limited data are available
specifically focussing on the resident loved ones' perception of the COPD
patient*s health status, the resident loved ones' lifestyle and their possible
interaction. Furthermore, loved ones' burden and health in relation to
exacerbation-related hospital admission of the person with COPD are not
investigated until now.
Study objective
Primary objectives:
1.1 To investigate the differences between patients* and resident loved ones'
perceptions of patients* health status and problematic ADLs.
1.2 To study prospectively the effects of an acute COPD exacerbation on
resident loved ones' perceptions of patients* health status and problematic
ADLs.
Secondary objectives:
2.1 To investigate the differences between patients* and resident loved ones*
perceptions of patients* mood status, care dependency and daily symptoms.
2.2 To study the relationship between lifestyle factors in COPD patients and
their resident loved ones.
2.3 To study prospectively the effects of an acute COPD exacerbation on
resident loved ones* perceptions of patients* mood status, care dependency and
daily symptoms.
2.4 To investigate resident loved ones* burden due to patients care dependency.
2.5 To investigate the general wellbeing of patients when discrepancies exist
between the patients* and resident loved ones* perceptions of patients* care
dependency.
2.6 To investigate if general wellbeing of resident loved ones is influenced by
the health status of patients.
2.7 To investigate if general wellbeing of patients is influenced by the mood
status of their resident loved ones.
2.8 To investigate whether and to what extent loved ones* burden and resident
loved ones* health and mood status are influenced by exacerbation-related
hospital admissions.
2.9 To investigate resident loved ones* knowledge about COPD and the
relationship with anxiety and social support.
2.10 To explore causes for a difference in perception between patients and
loved one*s about the problems in everyday life of the patient.
Study design
The Home Sweet Home study is an observational, longitudinal study.
Study burden and risks
To minimize participants* burden, all tests and questionnaires will be assessed
during home visits. A minimal of two visits is planned, one visit at baseline
and one visit after 12 months. Both visits take about 2.5 hours for the person
with COPD and 3 hours for the resident loved one. Two additional home visits
will be planned when an exacerbation-related hospital admission occurs during
12 months follow-up. Within seven days after admission, the loved one will be
visited at home. This visit will take about 2 hours. Two weeks after discharge,
the second visit will take place. The duration of this visit, in which both the
person with COPD and the loved one are participating, is equal to the duration
of the baseline visit. All procedures in this study are in use in everyday
clinical practice. Only the post-bronchodilator spirometry could give some
risks. Side effects only occur in minimal cases. Possible side effects are:
irritation of the mouth and throat, nausea, vibrations of fingers and hands,
headache, restlessness, rapid heartbeat, palpitations and high blood pressure.
About ten patients with COPD and ten loved ones will be asked to participate in
one qualitative interview after completing the baseline and follow-up visits of
the Home Sweet Home study. This qualitative interview with both the patient and
the loved one will be done during an additional home visit. The duration of the
follow-up measurement will be approximately one hour.
Hornerheide 1
Horn 6085 NM
NL
Hornerheide 1
Horn 6085 NM
NL
Listed location countries
Age
Inclusion criteria
- COPD as main diagnosis (GOLD stage II, III or IV according to GOLD guidelines);
- No exacerbation or hospitalization <4 weeks before enrolment;
- Providing written informed consent;
- One resident loved one also provided a written informed consent to participate.
Exclusion criteria
- Unable to complete the study questionnaires because of cognitive impairment as determined by the *Short Blessed Test*, for both the patient as well as the loved one;
- Unable to speak or understand Dutch, for both the patient as well as the loved one;
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL42721.060.12 |
OMON | NL-OMON24106 |